[Hepatitis associated with treatment with lovastatin. Presentation of 2 cases].
Two women of 57 and 59 years of age, presented anicteric hepatitis at 9 months and 3 years, respectively, of the initiation of treatment with lovastatin (20 mg/day) for hypercholesterolemia. In both cases other causes of liver damage were excluded and the analytical alterations normalized within a few weeks following discontinuation of the medication.
Bruguera
M
M
Servicio de Hepatología, Hospital Clínic i Provincial de Barcelona.
Joya
P
P
Rodés
J
J
D000924:Anticholesteremic Agents / Q000009:adverse effects*; D056486:Chemical and Drug Induced Liver Injury / Q000209:etiology*; D005260:Female; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000009:adverse effects*; D008148:Lovastatin / Q000009:adverse effects*; D008875:Middle Aged
D000924:Anticholesteremic Agents; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D008148:Lovastatin
Hepatitis asociada al tratamiento con lovastatina. Presentación de 2 casos.